Duan Fang-Rong, Yuan Bao-Qiang
Department of Pediatrics, Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu 221002, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2008 Jun;10(3):367-70.
To study the effect of extracts of Ginkgo biloba leaf (EGb), a catalyzer of central nervous system, on learning-memory ability and possible mechanism in rats with kindling-induced epilepsy.
Forty postnatal day 21 (P21) and 40 postnatal day 35 (P35) Sprague-Dawley (SD) rats were randomly respectively assigned to five groups: normal sodium (NS) control, kindling epilepsy model, high, middle and low dosage of EGb-treated kindling epilepsy. The kindling epilepsy model was established by an intraperitoneal injection of pentetrazole (PTZ). The learning-memory ability and NMDA receptor 1 (NMDAR1) expression in the hippocampus were measured by Y-maze test and immunohistochemistry assay respectively.
The stimulation times for reaching to academic standard in the Y-maze test in the two ages PTZ kindling groups was significantly more than that in the corresponding NS control groups (P<0.01). After EGb treatment the achievement of the Y-maze test in the three treatment groups was significantly improved in a dose-dependent manner, the higher the dosage, the better the achievement (P<0.01). Immunohistochemistry assay showed that the expression of NMDAR1 in the two ages PTZ kindling groups was significantly higher than that in the corresponding NS control groups (P<0.01). Compared with the corresponding untreated kindling model groups, the expression of NMDAR1 in the two ages EGb treatment groups was significantly reduced in a dose-dependent manner (P<0.01).
EGb can improve learning-memory ability in epileptic rats at different developmental phases in a dose-dependent manner, possibly through a reduction of NMDAR1 expression in the hippocampus.
研究中枢神经系统催化剂银杏叶提取物(EGb)对点燃诱导癫痫大鼠学习记忆能力的影响及其可能机制。
将40只出生后第21天(P21)和40只出生后第35天(P35)的Sprague-Dawley(SD)大鼠分别随机分为五组:正常钠(NS)对照组、点燃癫痫模型组、高、中、低剂量EGb治疗的点燃癫痫组。通过腹腔注射戊四氮(PTZ)建立点燃癫痫模型。分别采用Y迷宫试验和免疫组织化学分析法检测海马区学习记忆能力和N-甲基-D-天冬氨酸受体1(NMDAR1)表达。
两个年龄阶段的PTZ点燃组在Y迷宫试验中达到学习标准的刺激次数显著多于相应的NS对照组(P<0.01)。EGb治疗后,三个治疗组在Y迷宫试验中的成绩均呈剂量依赖性显著改善,剂量越高,成绩越好(P<0.01)。免疫组织化学分析显示,两个年龄阶段的PTZ点燃组中NMDAR1的表达显著高于相应的NS对照组(P<0.01)。与相应的未治疗点燃模型组相比,两个年龄阶段的EGb治疗组中NMDAR1的表达均呈剂量依赖性显著降低(P<0.01)。
EGb可剂量依赖性地改善不同发育阶段癫痫大鼠的学习记忆能力,可能是通过降低海马区NMDAR1的表达实现的。